The U.S. Food and Drug Administration has delayed its decision on Eli Lilly’s LLY.N experimental treatment for early Alzheimer’s disease and will hold a meeting of ...
By Olivia Skordi
September is recognised as the month of Alzheimer’s, with September 21 dedicated as an awareness day of Alzheimer’s disease, targeting communities to raise awareness and educate ...
The government will explore the possibility of supporting the establishment of an autism centre in Famagusta, deputy social welfare minister Marilena Evangelou said on Friday.
The minister visited three different ...
An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals ABOS.O targeting a novel form of the toxic protein beta amyloid in the brain passed an early safety test ...
The lack of dedicated facilities for Alzheimer’s patients and the almost total absence of state support came up in parliament on Thursday, with government officials promising to take a ...
An experimental Alzheimer‘s drug from Eisai 4523.T and Biogen BIIB.O slowed cognitive decline in a closely watched trial but may carry a risk of serious side effects for ...
Eisai Co Ltd 4523.T and Biogen Inc BIIB.O said their experimental Alzheimer’s drug significantly slowed cognitive and functional decline in a large trial of patients in the early ...
A crucial government plan to improve treatment is still being assessed, leaving families and charities to cope as best they can
Worldwide, dementia is viewed as an epidemic, with over 55 ...